• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
CHEN Jiahui, PING Qineng, SUN Minjie. Preparation of indomethacin-nicotinamide cocrystal by hot melt extrusion and its release in vitro[J]. Journal of China Pharmaceutical University, 2019, 50(2): 180-187. DOI: 10.11665/j.issn.1000-5048.20190208
Citation: CHEN Jiahui, PING Qineng, SUN Minjie. Preparation of indomethacin-nicotinamide cocrystal by hot melt extrusion and its release in vitro[J]. Journal of China Pharmaceutical University, 2019, 50(2): 180-187. DOI: 10.11665/j.issn.1000-5048.20190208
shu

Preparation of indomethacin-nicotinamide cocrystal by hot melt extrusion and its release in vitro

More Information
    Graphical Abstract
    • Abstract
  • Abstract The indomethacin-nicotinamide cocrystal was prepared by hot melt extrusion(HME)to improve the dissolution of indomethacin in vitro. The optimum preparation conditions were investigated using temperature and rotate speed as variables. Thermogravimetric analysis(TGA), determination of content and determination of related substances were performed to evaluate the thermal stability of indomethacin during the process. Cocrystal was also prepared by solution crystallization from acetonitrile. The products obtained by the two methods were characterized by differential scanning calorimetry(DSC), Fourier transform infrared(FTIR)and powder X-ray diffraction(PXRD). The solubility and dissolution advantages of cocrystal were evaluated. The results showed that the HME method could successfully prepare the indomethacin-nicotinamide cocrystal at 115 °C and eutectic mixture was formed during the process. The cocrystal significantly improved the solubility and dissolution of indomethacin in deionized water, with pH 5. 5 and pH 6. 8 phosphate buffer. The preparation of poorly soluble drug cocrystal by HME can significantly improve its solubility, providing new idea for the development of poorly soluble drugs and HME technology.
    • FullText(HTML)
    • References (21)
  • [1]
    Karagianni A, Malamatari M, Kachrimanis K. Pharmaceutical cocrystals:new solid phase modification approaches for the formulation of APIs[J].Pharmaceutics,2018,10(1):18.
    [2]
    Sathisaran I,Dalvi SV.Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium[J].Pharmaceutics,2018,10(3):108.
    [3]
    Liu M,Hong C,Yao YS,et al.Development of a pharmaceutical cocrystal with solution crystallization technology:preparation,characterization,and evaluation of myricetin-proline cocrystals[J].Eur J Pharm Biopharm,2016,107:151-159.
    [4]
    Zhou SY, Zhang BW, Wei YF, et al. Enhanced dissolution and oral bioavailability of baicalein by cocrystallization[J].J China Pharm Univ(中国药科大学学报),2018,49(6):682-688.
    [5]
    Denga JH,Lu TB,Sun CC,et al.Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin[J].Eur J Pharm Sci,2017,104(15):255-261.
    [6]
    Zhang YZ,Yao J,Yin DD.Properties and dissolution in vitro of indomethacin soluplus amorphous preparation[J].Chin New Drugs J(中国新药杂志),2016,25(7):830-835.
    [7]
    Kojima T, Tsutsumi S, Yamamoto K, et al. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate[J].Int J Pharm,2010,399(1):52-59.
    [8]
    Bordignon S,Vioglio PC,Priola E,et al.Engineering codrug solid forms:mechanochemical synthesis of an indomethacin-caffeine system[J].Cryst Growth Des,2017,17(11):5744-5752.
    [9]
    Majumder M,Bucktona G,Rawlinson-Malone C,et al.A carbamazepine-indomethacin(1∶1)cocrystal produced by milling[J].CrystEngComm,2011,13(21):6327-6328.
    [10]
    Majumder M,Buckton G,Rawlinson-Malone CF.Application of hydrogen-bond propensity calculations to an indomethacin-nicotinamide(1∶1)co-crystal[J].Cryst Eng Comm,2013,15(20):4041-4044.
    [11]
    Abdallah DM.Nicotinamide alleviates indomethacin-induced gastric ulcers:a novel antiulcer agent[J].Eur J Pharmacol,2010,627(1/2/3):276-280.
    [12]
    Douroumis D, Ross SA, Nokhodchi A. Advanced methodologies for cocrystal synthesis[J].Adv Drug Deliv Rev,2017,117(1):178-195.
    [13]
    Moradiya HG,Islam MT,Halsey S,et al.Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing[J].CrystEngComm,2014,16(17):3573-3583.
    [14]
    Medina C,Daurio D,Nagapudi K,et al.Manufacture of pharmaceutical cocrystals using twin screw extrusion:a solvent-less and scalable process[J].J Pharm Sci,2010,99(4):1693-1696.
    [15]
    Daurio D, Nagapudi K, Li L, et al. Application of twin screw extrusion to the manufacture of cocrystals:scale-up of AMG 517-sorbic acid cocrystal production [J].Faraday Discuss,2014,170:235-249.
    [16]
    Haser A,Huang S,Listro T,et al.An approach for chemical stability during melt extrusion of a drug substance with a high melting point[J].Int J Pharm,2017,524(1/2):55-64.
    [17]
    Lin HL,Zhang GC,Huang YT,et al.An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state[J].J Pharm Sci,103(8):2386-2395.
    [18]
    Bogdanova SV, Sidzhakova D, Karaivanova V. Aspects of the interactions between indomethacin and nicotinamide in solid dispersions[J].Int J Pharm,1998,163(1/2):1-10.
    [19]
    Dhumal RS,Kelly AL,York P,et al.Cocrystalization and simultaneous agglomeration using hot melt extrusion[J].Pharm Res,2010,27(12):2725-2733.
    [20]
    Hu LH,Chen L,Fang YH,et al.Molecular structure and physical property estimation of deep eutectic solvents[J].Chem Reagents(化学试剂),2017,39(9):937-941.
    [21]
    Alhalaweh A,Sokolowski A,Rodríguez-Hornedo N,et al.Solubility behavior and solution chemistry of indomethacin cocrystals in organic solvents[J].Cryst Growth Des,2011,11(9):3923-3929.
    • Related Articles

  • Related Articles

    [1]ZHAO Xiaomei, WANG Xin, JI Xia, ZHANG Hua, ZHANG Pingping, HU Guoqiang. Synthesis and antitumor activities of 1, 2-benzothiazines［1, 3, 4］thiadiazolo［3, 2-a］［1, 3, 5］triazin derivatives[J]. Journal of China Pharmaceutical University, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104
    [2]LI Jing, REN Yuejiao, GUAN Su, ZHANG Lei. Synthesis and xanthine oxidase inhibitory activities of 2-phenyl-tetrahydrothiopyrano［4, 3-d］ pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(3): 294-300. DOI: 10.11665/j.issn.1000-5048.20150306
    [3]DENG Lian-bai, LI Ai-xiu, JIN Yu-rui. Advances in the study on inhibitors of RNase H,a novel anti-HIV drug target[J]. Journal of China Pharmaceutical University, 2011, 42(6): 578-584.
    [4]DU Ping, ZHANG Di, ZHANG Guo-min, REN Shu-juan, GONG Guo-qing, XU Yun-gen. Synthesis and Na+/H+ exchanger 1 inhibitory activity of substituted benzoylguanidine-trimetazidine conjugates[J]. Journal of China Pharmaceutical University, 2011, 42(1): 22-28.
    [5]Synthesis and Biological Activity Study on N-( 3,4- Dimethoxyphenylethyl )-4-Subtituted Phenylpiperazine-1- Acetamide Series as α1-Adrenoceptor Antagonists[J]. Journal of China Pharmaceutical University, 2004, (1): 9-13.
    [6]Synthesis and Biologic Activities on 1-{1-[2-(3,4-Dimethoxy)Phenylethyl]-5-Cyano-6-Methyl-Uracil-3yl}-3-Substituted Amino-2-Propanol Compounds[J]. Journal of China Pharmaceutical University, 2003, (5): 10-13.
    [7]Synthesis andAntihypertensive Activity of 1-Phenylethyl(or 3,4-Dimethyloxyphenylethyl)-4-substitutedAryloxypiperidines[J]. Journal of China Pharmaceutical University, 2001, (3): 22-26.
    [8]Synthesis and Bioactivity of 1-Aryl-3-Alkyl-1, 4-Dihydro-4-Substituted-5H-1,2,4-triazolinones-5[J]. Journal of China Pharmaceutical University, 1999, (5): 323-327.
    [9]Synthesis and Inhibitor Activity to Phosphodiesterase of Thieno [3, 4-d] Pyrimidine-2,4-Dione Derivatives[J]. Journal of China Pharmaceutical University, 1991, (3): 142-144.
    [10]Synthesis of Thieno [3,4-d] Pyrimidine-2,4-Dione Derivatives[J]. Journal of China Pharmaceutical University, 1990, (4): 193-197.

Catalog

    Get Citation
    PDF
    XML
    Article views (921) PDF downloads (1252) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：295151

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return